Bimekizumab vs Metformin

## Bimekizumab vs Metformin: Overview

This comparison examines the pharmacological differences between **Bimekizumab** and **Metformin**.

## Mechanism of Action

**Metformin**: Activates AMP-activated protein kinase, decreasing hepatic glucose production.

## Pharmacokinetics

**Half-life**: Bimekizumab — N/A; Metformin — 4-9 hours.

## Chemical Properties

**Molecular Formula**: Bimekizumab — N/A; Metformin — C4H11N5.

**Molecular Weight**: Bimekizumab — N/A; Metformin — 129.1640 g/mol.

**Type**: Bimekizumab — Antibody; Metformin — Small molecule.